Novel Therapy With Ramelteon for Hypoactive Delirium: A Case Report

J Clin Psychopharmacol. 2015 Oct;35(5):616-8. doi: 10.1097/JCP.0000000000000370.

Authors

Shoko Miura¹, Motohide Furuya, Hideaki Yasuda, Tsuyoshi Miyaoka, Jun Horiguchi

Affiliation

¹ Department of Psychiatry Shimane University Faculty of Medicine Izumo, Japan [email protected] Department of Psychiatry and Department of Developmental Biology Shimane University Faculty of Medicine Izumo, Japan Department of Psychiatry Shimane University Faculty of Medicine Izumo, Japan and Department of Psychiatry Sekitou Hospital Oda, Japan Department of Psychiatry Shimane University Faculty of Medicine Izumo, Japan.

PMID: 26114404
DOI: 10.1097/JCP.0000000000000370

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Delirium / drug therapy*
Delirium / physiopathology
Humans
Indenes / therapeutic use*
Male
Middle Aged
Receptor, Melatonin, MT1 / agonists
Receptor, Melatonin, MT2 / agonists
Treatment Outcome

Substances

Indenes
Receptor, Melatonin, MT1
Receptor, Melatonin, MT2
ramelteon